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Induction of heparin-binding epidermal growth factor-like growth
factor mRNA by protein kinase C activators. Heparin-binding epidermal
growth factor-like growth factor (HB-EGF) is a potent smooth muscle cell
mitogen of macrophage origin. To determine whether the HB-EGF gene
is transcribed and regulated in mesangial cells, we measured HB-EGF
mRNA levels in cultured rat mesangial cells by RNA blot analysis. A
2.5-kb HB-EGF mRNA was detected in unstimulated mesangial cells. The
protein kinase C activator 12-O-tetradecanoylphorbol 13-acetate (TPA)
increased HB-EGF mRNA levels by 15-fold in mesangial cells, and this
induction of HB-EGF mRNA by TPA was both time- and dose-depen-
dent. HB-EGF mRNA could also be stimulated by 10% fetal calf serum,
ionomycin, thrombin, and endothelin-1. Staurosporine, a protein kinase C
inhibitor, abolished the induction of HB-EGF mRNA by TPA and serum.
To determine whether HB-EGF is mitogenic for mesangial cells, we
transfected COS cells with HB-EGF expression plasmids. Culture medium
from COS cells transfected with these plasmids increased 3H-thymidine
incorporation in mesangial cells in a dose-dependent manner. To our
knowledge, this is the first report that HB-EGF is expressed in renal cells.
This inducible transcription of HB-EGF suggests that it may have an
autocrine role in mesangial cell proliferation in kidney disease.
Heparin-binding epidermal growth factor-like growth factor
(HB-EGF), a potent mitogen for vascular smooth muscle cells
and fibroblasts, was purified from conditioned medium in which
macrophage-like U-937 cells had been cultured [1]. HB-EGF is a
member of the epidermal growth factor (EGF) family because it
contains an EGF-like domain and binds EGF receptors with high
affinity. HB-EGF is a more potent smooth muscle cell mitogen
than EGF, probably because HB-EGF binds heparin. Its potency
is similar to that of platelet-derived growth factor [1]. We have
found that the HB-EGF gene is expressed in a highly regulated
manner by cytokines in vascular endothelial cells [2] and by
phorbol esters and angiotensin II in aortic smooth muscle cells [3].
This inducible expression of HB-EGF suggests that it may have an
important role in the proliferation of smooth muscle cells during
atherogenesis [3].
Glomerular mesangial cells exhibit some features of smooth
muscle cells and macrophages [4—6] and play a crucial role in the
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mediation of glomerular injury [7—9]. Mesangial cell proliferation
followed by glomeruloscierosis is a prominent feature of the
response to local inflammation in glomerulonephritis and renal
injury [10, 11], a situation similar to the proliferation of smooth
muscle cells in atherosclerosis [12]. Yet despite extensive re-
search, the biochemical basis underlying mesangial cell prolifera-
tion is unclear. We postulate that the peptide growth factor
HB-EGF may have an important role in this proliferation process.
To determine whether the HB-EGF gene is transcribed and
regulated in mesangial cells, we measured HB-EGF mRNA levels
in cultured rat mesangial cells in response to a variety of stimuli by
RNA blot analysis. Moreover, to test whether HB-EGF has a
mitogenic effect on mesangial cells, we measured mesangial cell
DNA synthesis after the addition of medium from COS cells
transfected with HB-EGF expression plasmids.
Methods
Cell culture
Mesangial cells were isolated and cultured from rat renal
glomeruli according to the methods of Harper et al [13] with some
modification. Briefly, glomeruli were harvested from six to eight
male Sprague-Dawley rats (150 to 200 g) by sieving the renal
cortices, which were then digested with 0.25% trypsin and 0.05%
collagenase. The digested glomeruli were incubated at 37°C in
RPMI 1640 medium containing 20% fetal calf serum (FCS),
penicillin (100 U/ml), streptomycin (100 p.g/ml), and insulin (0.6
U/mi). After two to three weeks mesangial cells appeared and
they were characterized by previously reported methods [14, 15].
On phase contrast microscopy, the cells were stellate or spindle
shaped in appearance, and in postconfluent culture they piled and
formed small nodules. The cells were sensitive to mitomycin C,
but not to aminonucleoside of puromycin and they contracted in
response to angiotensin II. In addition, the cells failed to stain for
Ia and leukocyte common antigen. The cells were passaged every
four to six days. Cells from passages 9 to 18 were used in the
experiments. Confluent cells were starved by incubation in me-
dium containing 0.5% FCS for 24 hours before addition of
reagents.
RNA isolation and RNA blot analysis
Total cellular RNA was isolated according to the acid guani-
dinium thiocyanate-phenol-chioroform method of Chomczynski
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- 1-actn Fig. 1. Effects of serum on HB-EGF mRNA
levels in rat mesangial cells. A. Mesangial cells
were starved by incubation in medium
containing 0.5% fetal calf serum (FCS) for 24
hours followed by stimulation with 10% FCS
for 0.5, 1, 2, and 4 hours. Total RNA was
extracted and RNA blot analysis was performed
with 20 gig/lane. After electrophoresis the RNA
was transferred to nylon filters, which were then
hybridized to 32P-labeled rat HB-EGF and
13-actin probes. The signal from each RNA
sample was measured by densitometly. To
correct for differences in RNA loading, the
signal density for each RNA sample hybridized
to the HB-EGF probe was divided by that for
each sample hybridized to the f3-actin probe. B.
The corrected density for each lane was divided
by that of the control cells (baseline) and
plotted in relative units against time.
Fig. 2. Time course of the effect of TPA on HB-
EGF mRNA levels in rat mesangial cells. A.
Mesangial cells were starved as described for
Fig. 1 and exposed to 500 nM of TPA. Total
RNA was extracted at the indicated times.
RNA blots (20 jg/lane) were hybridized to 32P-
labeled rat HB-EGF and $3-actin probes. Signal
density was measured as described for Fig. 1. C,
RNA sample from control cells at time zero; D,
RNA sample from cells treated with vehicle
(DMSO) for 60 minutes. B. Corrected density
for each lane plotted in relative units against
time.
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Fig. 3. Dose response of the effect of TPA on HB-EGF mRNA levels in rat
mesangial cells. A. Mesangial cells were starved as described for Fig. 1 and
exposed to the indicated concentrations of TPA. Total RNA was extracted
at 60 minutes. RNA blots (20 jzgllane) were hybridized to 32P-labeled rat
HB-EGF and 13-actin probes. Signal density was measured as described for
Fig. 1. C, RNA sample from unstimulated control cells at time zero; D,
RNA sample from cells treated with vehicle (DMSO) for 60 minutes. B.
Corrected density for each lane plotted in relative units against dose.
and Sacchi [16]. RNA (20 pg/lane) was separated by 1% agarose/
formaldehyde gel electrophoresis and transferred to nylon filters.
The filters were hybridized with a random-primed 32P-labeled rat
HB-EGF eDNA probe according to a standard technique [3, 17].
Then the filters were washed in 30 m'vi NaCl, 3 mM sodium citrate,
and 0.1% sodium dodecyl sulfate at 65°C. The filters were
autoradiographed with Kodak X-OMAT-AR film for 24 to 72
hours at —70°C. To correct for differences in RNA loading, we
subsequently rehybridized the filters with a 3-actin eDNA probe.
Each lane of the autoradiographs was measured in a densitometer
(Molecular Dynamics, model 100S).
Transfection of HB-EGF plasmids to COS cells and 3H-thymidine
incorporation
Transfcction was performed according to the DEAE-dextran
method of Sambrook, Fritsch and Maniatis [17], and Gerard and
Gluzman [18] with some modification. A human HB-EGF con-
struct (excluding the intracellular and transmembrane regions)
was cloned into the expression vector pcDNA1 (Invitrogen, San
Diego, California, USA). The mammalian COS metallothionein
cell line (a gift from Y. Gluzman, Pearl River, New York, USA)
was grown in Dulbecco's modified Eagle's medium (DMEM)
containing 10% Serum Plus® (JRH Biosciences, Lenexa, Kansas,
USA). On the day of transfection, the COS cells were trypsinized
and cultured in medium containing DEAE-dextran (400 g/ml),
chioroquine (100 MM), and HB-EGF expression plasmids or vector
alone (1 p.g/ml) for three hours. After a wash with Dulbecco's
phosphate-balanced saline (DPBS), the COS cells were exposed to
10% dimethyl sulfoxide in DPBS for two minutes, followed by
— HB-EGF incubation in medium containing TPA (30 ng/ml) for 30 minutes(to improve transfection efficiency). The next day zinc sulfate (100
was added for 48 hours to activate the metallothionein
promoter. The COS cells were then cultured in serum-free
DMEM containing zinc sulfate (100 M) for another 24 hours. To
demonstrate that COS cells transfected with expression plasmids
secrete HB-EGF, medium from COS cells transfected with vector
— 13-actin alone or HB-EGF expression plasmids was collected and was
analyzed by Western blotting. Equal amount of vector or HB-
EGF COS medium was concentrated and fractionated with
tricine-sodium dodecyl sulfate-polyaciylamide gel electrophoresis
(SDS-PAGE) [19]. Proteins were transferred to polyvinylidene
difluoride membrane (Immobilon-P, Millipore, Bedford, Massa-
chusetts, USA). The membrane was initially treated with 5%
nonfat milk for one hour. This was followed by incubation with a
rabbit anti-human HB-EGF antibody (1:2000) [20] at 4°C over-
night. Finally, the membrane was treated with alkaline phos-
phatase-conjugated goat anti-rabbit IgG (1:5000) for one hour at
room temperature and then was developed with NBT/BCIP
subtrates after washing. To determine 3H-thymidine incorpora-
tion, confluent mesangial cells were made quiescent by incubation
in DMEM with 0.4% calf serum for 72 hours before the addition
of COS cell medium. Twenty-four hours after the addition of COS
cell medium the cells were incubated with 1 /LCi/ml [methyl-31-I]-
thymidine (specific activity, 20 Ci/mmol) for three hours. Incor-
porated 3H-thymidine was measured in a liquid scintillation
counter.
Reagents
RPMI 1640 medium, DMEM, and DPBS used for cell culture
were purchased from Gibco BRL (Gaithersburg, Maryland,
USA). Fetal calf serum was obtained from Biological Industries
(Kibbutz Bet HaEmek, Israel). The following reagents were
purchased from Sigma (St. Louis, Missouri, USA): 12-0-tetra-
decanoylphorbol 13-acetate (TPA), staurosporine, ionomycin,
thrombin, DEAE-dextran, dimethyl sulfoxide (DMSO), chioro-
quine, and zinc sulfate. Endothelin-1 was purchased from Penin-
sula (Belmont, California, USA) and [methyl-3H]-thymidine from
DuPont/NEN (Boston, Massachusetts, USA).
Results
To test whether mesangial cells transcribe the HB-EGF gene,
we performed Northern blot analysis with RNA extracted from
cultured rat mesangial cells. A 2.5-kb HB-EGF message was
detected in RNA prepared from mesangial cells cultured in
medium containing 0.5% FCS (Fig. 1). After the addition of 10%
FCS HB-EGF mRNA was induced within one hour, and induc-
tion peaked at two hours (4-fold increase). To determine whether
activation of protein kinase C was involved in the induction of
HB-EGF, we treated mesangial cells with TPA, a direct protein
kinase C activator. Induction of HB-EGF mRNA by TPA was
both time- and dose-dependent (Figs. 2 and 3). HB-EGF mRNA
levels increased within 40 minutes and peaked at 120 minutes
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Fig. 4. Effect of staumsporine on levels of HH-
EGF mRNA induced by TPA in rat mesa ngial
cells. A. Mesangial cells were starved as
described for Fig. 1 and pretreated with the
indicated concentrations of staurosporine for 15
minutes followed by the addition of TPA (500
flM) for 2 hours. Total RNA was extracted at
the end of incubation. RNA blots (20 pg/lane)
were hybridized to 32P-labeled rat HB-EGF and
/3-actin probes. Signal density was measured as
described for Fig. 1. B. Corrected density for
each lane plotted in relative units against dose.
(15-fold increase over control). Induction by TPA began at 5 n
and plateaued at 50 n (Fig. 3).
To confirm whether HB-EGF mRNA induction was protein
kinase C-dependent, we tested the effect of the protein kinase C
inhibitor staurosporine on HB-EGF mRNA. Mesangial cells were
treated with S to 1000 nM of staurosporine for 15 minutes before
incubation with TPA (500 nM) for two hours. Staurosporine
decreased HB-EGF mRNA induction due to WA in a dose-
dependent manner (Fig. 4). At 100 to 500 ni, staurosporine
completely abolished induction of HB-EGF rnRNA by TPA (Fig.
4) as well as serum (data not shown). Thus, induction of HB-EGF
mRNA by both TPA and serum appears to depend on protein
kinase C. We also treated mesangial cells with ionomycin (5 pM),
thrombin (5 U/mI), and endothelin-1 (0.1 pM) to see whether
HB-EOF mRNA was induced by other agents known to activate
the phospholipase C/Ca2/protein kinase C pathway. All three
agents markedly increased HB-EGF mRNA levels (Fig. 5).
Finally, to determine whether HB-EGF has a mitogenic effect
on mesangial cells, HB-EGF was expressed in COS cells, and the
serum free medium conditioned by these cells was applied to
mesangial cells. To demonstrate the presence of HB-EGF in the
COS cell medium, we performed Western blot analysis using a
polyclonal antibody directed against recombinant human HB-
EGF (Fig. 6A). Multiple forms of HB-EGF were detected only in
the medium from HS-EGF transfected cells. This is consistent
with previous reports that multiple forms of HB-EGF are de-
tected in culture medium of U-937 cells [21]. HB-EGF COS
medium stimulated DNA synthesis in mesangial cells in a dose-
dependent manner (Fig. 6B). As little as 1% HB-EGF COS
medium increased 3l-I-thymidine incorporation by 24%, and the
maximal stimulatory effect (66% over control) was obtained with
10% HB-EGF COS medium. Vector COS medium did not
significantly affect 3H-thymidine incorporation in mesangial cells.
Discussion
Our study indicates that HB-EGF mRNA is constitutively
transcribed in cultured rat mesangial cells and that HB-EGF
mRNA can be markedly induced by agents that activate the
protein kinase C pathway. We also show that culture medium
from COS cells transfected with HB-EGF expression plasmids is
mitogenic for mesangial cells. It has been reported that the
HB-EGF gene is expressed in macrophages, vascular endothelial
cells, and smooth muscle cells [1—3, 20]. To our knowledge this is
the first demonstration that renal cells express HB-EGF mRNA.
It has also been reported that both the EGF peptide and its
receptor are present in the kidney [22—24]. However, EGF is
produced mainly by the renal tubules [25], and there is no
evidence to suggest that mesangial cells produce EGF. Mesangial
cells do possess functional EGF receptors, and exogenous EGF
can cause these cells to grow and contract [24]. HB-EGF binds
these £GF receptors with high affinity [1], and, as this report
shows, the HB-EGF gene is expressed in mesangial cells. HB-
EGF may therefore have an important autocrine role in modu-
lating the function of mesangial cells.
Activation of protein kinase C is associated with biological
events in mesangial cells that include induction of DNA synthesis
and protein phosphorylation [26—28]. Our study indicates that
protein kinase C activation has an important role in the induction
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Fig. S. Effect of ionamycin, thrombin, and endothelin-1 on levels of HB-
EGE mRNA in rat mesangial cells. A. Mesangial cells were starved as
described for Fig. 1 and exposed to TPA (500 nM), ionomycin (5 gM),
thrombin (5 U/mI), and endothelin-1 (0.1 JLM). Total RNA was extracted
after 2 hours. RNA blots (20 sg,/lane) were hybridized to 32P-labeled rat
HB-EGF and /3-actin probes. Signal density was measured as described for
Fig, 1. B. Corrected density for each lane plotted in relative units against
different reagents.
Fig. 6. A. Western blotting of HB-EGF protein in culture medium from COS
cells transfected with HB-EGF. SDS-PAOE demonstrated the multiple
forms of HB-EGF protein in medium from COS cells transfected with
HB-FGF expression plasmids (HB-EGF) rather than in medium from
COS cells transfected with vector only (Vector). B. Mitogenic effect of
HB-EGF COS medium on mesangial cells. Mesangial cells in 24-well
culture plates were starved by incubation in medium with 0.4% calf serum
for 72 hours. They were exposed to the indicated concentrations of culture
medium from COS cells transfected with HB-EGF expression plasmids(HB-EGF, —) or vector alone (vector, Q—Q) for 24 hours.
3H-thymidine incorporation (1 pCi/mI) was measured during the last 3
hours of incubation. The percentage of change in epm relative to control
(mean cpm, 12101; N = 5) is shown.
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of HB-EGF mRNA. We base this conclusion on our finding that
TPA stimulated HB-EGF mRNA induction in a time- as well as
dose-dependent manner (Fig. 3), and staurosporine abolished
induction of HB-EGF mRNA by TPA (Fig. 4) or serum (data not
shown). Moreover, ionomycin, thrombin, and endothelin-1 also
markedly stimulated the induction of HB-EGF mRNA. Thus,
phospholipase C/Ca21jprotein kinase C signal transduction may
play an important role in regulating induction of the HB-EGF
gene. This conclusion also implies that DNA synthesis induced
by protein kinase C activation in mesangial cells [261 may be
mediated by a potent mitogen such as HB-EGF.
Peptide growth factors such as platelet-derived growth factor,
basic fibroblast growth factor, and insulin-like growth factor have
been implicated as mediators of mesangial cell proliferation in
response to local inflammation in glomerulonephritis and renal
injury [29—32]. Our demonstration that culture medium from
COS cells transfected with HB-EGF expression plasmids has a
mitogenic effect on mesangial cells indicates that HB-EGF may
also contribute to the proliferation of these cells in glomerular
injury. However, we cannot exclude the possibility that HB-EGF
produced by the COS cells may act in an autoerine manner to
—10
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COS medium, %
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stimulate the COS cells to produce other cytokines which might
promote mesangial cell proliferation.
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